Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies

Léa Dousset1, Katia Boniface2, Julien Seneschal3,2

  • 1Department of Dermatology and Pediatric Dermatology, National Center for Rare Skin Disorders, Saint-André and Pellegrin Hospitals, Bordeaux, France.

Insights

Vitiligo-like lesions are common skin side effects of anti-programmed cell death 1 (PD-1) cancer therapies. These lesions may indicate a better response to immunotherapy and improved patient survival.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Antibody-based therapies targeting programmed cell death 1 (PD-1) are effective against metastatic cancers like melanoma.
  • Restoring immune function with anti-PD-1 therapies can cause immune-related adverse events, including cutaneous events.
  • Vitiligo-like lesions are a frequent skin adverse event associated with anti-PD-1 treatment, potentially more common than with other immunotherapies.

Purpose of the Study:

  • To review the clinical presentation of vitiligo-like lesions in patients treated with anti-PD-1 therapies.
  • To explore hypothesized mechanisms underlying the development of these lesions.
  • To discuss the potential association between vitiligo-like lesions and therapeutic response/patient survival.

Main Methods:

  • Literature review of clinical reports and studies on vitiligo-like lesions in patients receiving anti-PD-1 therapy.
  • Analysis of the incidence and clinical characteristics of these lesions across various metastatic cancers.
  • Synthesis of proposed immunological mechanisms potentially driving lesion development.

Main Results:

  • Vitiligo-like lesions are increasingly reported in patients with metastatic cancers treated with anti-PD-1 agents.
  • These lesions may differ from spontaneous vitiligo and have been linked to enhanced anti-tumor response.
  • Emerging evidence suggests a correlation between these lesions and improved patient survival outcomes.

Conclusions:

  • Vitiligo-like lesions are a significant cutaneous manifestation of anti-PD-1 therapy.
  • Understanding the mechanisms behind these lesions could offer insights into immunotherapy efficacy.
  • Further research is warranted to elucidate the prognostic implications of these lesions in cancer patients.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.8K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.4K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

4.0K
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
485
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.4K